chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Vaccination site rash
Clinical narrative: coughing; runny nose; coughing; chemical taste and smell after injection; chemical taste and smell after injection; chills; fatigue; rash around injection site; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of COUGH (coughing), RHINORRHOEA (runny nose), the second episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection) and PAROSMIA (chemical taste and smell after injection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced the first episode of COUGH (coughing), RHINORRHOEA (runny nose), the second episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection), PAROSMIA (chemical taste and smell after injection), CHILLS (chills), FATIGUE (fatigue) and VACCINATION SITE RASH (rash around injection site). At the time of the report, RHINORRHOEA (runny nose), the last episode of COUGH (coughing), DYSGEUSIA (chemical taste and smell after injection), PAROSMIA (chemical taste and smell after injection), CHILLS (chills), FATIGUE (fatigue) and VACCINATION SITE RASH (rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Sinusitis
Clinical narrative: Continuous headache; Sinus infection; A spontaneous report was received from a 66 year old , female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  continuous headache and sinus infection/sinusitis.  The patient's medical history was not provided. Concomitant product use was not reported.   On unknown date, prior to the onset of the events ,the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) continuous headache, sinus infection.Treatment details included antibiotic for sinus infection.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of event(s), continuous headache, sinus infection were considered to be unknown at the time of the report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Stiffness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness) and PAIN (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness) and PAIN (soreness). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness) and PAIN (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Vaccination site erythema, Vaccination site pain
Clinical narrative: redness; Arm was red; Arm discomfort/uncomfortable; Itchy; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), FEELING HOT (Hot to the touch), ERYTHEMA (redness), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE PAIN (Arm discomfort/uncomfortable) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Itchy), FEELING HOT (Hot to the touch), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE PAIN (Arm discomfort/uncomfortable). On 11-Feb-2021, the patient experienced ERYTHEMA (redness). At the time of the report, PRURITUS (Itchy), FEELING HOT (Hot to the touch), ERYTHEMA (redness), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE PAIN (Arm discomfort/uncomfortable) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that she felt fine. Patient used ice on the arm as a treatment.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up document received on 06 Jul 2021 included outcome of the events and an update that patient declined Further Follow-up. The event coding for arm discomfort and arm was red changed to vaccination site pain and vaccination site erythema respectively.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Itchy; Large red patches about 2&1/2 inches in diameter; painful(3 on scale of 1-10), .; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itchy), RASH ERYTHEMATOUS (Large red patches about 2&1/2 inches in diameter) and RASH (painful(3 on scale of 1-10), .) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dizziness, Feeling abnormal, Feeling cold
Clinical narrative: Feeling very groggy; Lost her balance; Felt like someone is pushing her; Drunk feeling; Very light headed; Arm started hurting; Chills; Headache; Cold feeling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold feeling), SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her) and FEELING DRUNK (Drunk feeling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced FEELING COLD (Cold feeling), VACCINATION SITE PAIN (Arm started hurting), CHILLS (Chills) and HEADACHE (Headache). On 05-Feb-2021, the patient experienced SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her), FEELING DRUNK (Drunk feeling) and DIZZINESS (Very light headed). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (Cold feeling), SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her), FEELING DRUNK (Drunk feeling), DIZZINESS (Very light headed), VACCINATION SITE PAIN (Arm started hurting), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were unspecified blood pressure medications.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling drunk, Headache, Somnolence, Vaccination site pain
Clinical narrative: Feeling very groggy; Lost her balance; Felt like someone is pushing her; Drunk feeling; Very light headed; Arm started hurting; Chills; Headache; Cold feeling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold feeling), SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her) and FEELING DRUNK (Drunk feeling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced FEELING COLD (Cold feeling), VACCINATION SITE PAIN (Arm started hurting), CHILLS (Chills) and HEADACHE (Headache). On 05-Feb-2021, the patient experienced SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her), FEELING DRUNK (Drunk feeling) and DIZZINESS (Very light headed). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (Cold feeling), SOMNOLENCE (Feeling very groggy), BALANCE DISORDER (Lost her balance), FEELING ABNORMAL (Felt like someone is pushing her), FEELING DRUNK (Drunk feeling), DIZZINESS (Very light headed), VACCINATION SITE PAIN (Arm started hurting), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were unspecified blood pressure medications.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site induration, Vaccination site pain
Clinical narrative: Body aches; pain; hardness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), VACCINATION SITE PAIN (pain) and VACCINATION SITE INDURATION (hardness) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (Body aches), VACCINATION SITE PAIN (pain) and VACCINATION SITE INDURATION (hardness). At the time of the report, PAIN (Body aches), VACCINATION SITE PAIN (pain) and VACCINATION SITE INDURATION (hardness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash, Vaccination site erythema, Vaccination site induration, Vaccination site mass
Clinical narrative: lump sized and shaped as a half hard boiled egg; lump sized and shaped as a half hard boiled egg; warm lump; red lump; rash all over her back; very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump) and RASH (rash all over her back) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump), RASH (rash all over her back) and FATIGUE (very tired). The patient was treated with OMEPRAZOLE at an unspecified dose and frequency; ZINC at an unspecified dose and frequency; CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) at an unspecified dose and frequency and MENADIONE (VITAMIN K [MENADIONE]) at an unspecified dose and frequency. On 01-Mar-2021, FATIGUE (very tired) outcome was unknown. At the time of the report, VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump) and RASH (rash all over her back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Follow up received on 1st May 2021 and it contains No New Information
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: lump sized and shaped as a half hard boiled egg; lump sized and shaped as a half hard boiled egg; warm lump; red lump; rash all over her back; very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump) and RASH (rash all over her back) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump), RASH (rash all over her back) and FATIGUE (very tired). The patient was treated with OMEPRAZOLE at an unspecified dose and frequency; ZINC at an unspecified dose and frequency; CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) at an unspecified dose and frequency and MENADIONE (VITAMIN K [MENADIONE]) at an unspecified dose and frequency. On 01-Mar-2021, FATIGUE (very tired) outcome was unknown. At the time of the report, VACCINATION SITE MASS (lump sized and shaped as a half hard boiled egg), VACCINATION SITE INDURATION (lump sized and shaped as a half hard boiled egg), VACCINATION SITE WARMTH (warm lump), VACCINATION SITE ERYTHEMA (red lump) and RASH (rash all over her back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Follow up received on 1st May 2021 and it contains No New Information
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Breast discharge, Breast pain, Pain
Clinical narrative: Her right breast got extremely sore; Aching; Leaking; Very painful; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Her right breast got extremely sore), PAIN (Aching), BREAST DISCHARGE (Leaking) and BREAST PAIN (Very painful) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Diabetes mellitus.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced BREAST PAIN (Her right breast got extremely sore), PAIN (Aching), BREAST DISCHARGE (Leaking) and BREAST PAIN (Very painful). At the time of the report, BREAST PAIN (Her right breast got extremely sore), PAIN (Aching), BREAST DISCHARGE (Leaking) and BREAST PAIN (Very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Illness
Clinical narrative: This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea) and ILLNESS (have been sick) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and ILLNESS (have been sick). At the time of the report, DIARRHOEA (diarrhea) and ILLNESS (have been sick) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication details was reported. Treatment medications provided by the reporter included anti diarrhea pills. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Exfoliative rash, Rash
Clinical narrative: it is scaly; dry patch on his arm  that went from the elbow to the base of the armpit; This spontaneous case was reported by a consumer and describes the occurrence of EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit). At the time of the report, EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include medicine for diabetes.      Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: NNI
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot to touch at injection site; Swelling at injection site; Very red at injection site; Difficulty breathing which lasted less than a minute; Tightness of breath; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site), DYSPNOEA (Difficulty breathing which lasted less than a minute) and CHEST DISCOMFORT (Tightness of breath) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart valve replacement.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site), DYSPNOEA (Difficulty breathing which lasted less than a minute) and CHEST DISCOMFORT (Tightness of breath). At the time of the report, VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site), DYSPNOEA (Difficulty breathing which lasted less than a minute) and CHEST DISCOMFORT (Tightness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included medications for heart valve replacement. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: follow-up received Patient declined further follow-up
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Ear pain, Flushing
Clinical narrative: mild allergic reaction; fast heartbeat/rapid heart rate; can't breathe/ trouble breathing; chest tightness; ear pain; felt flush in their head; arm soreness; headaches; dizziness three and a half hour after the shot; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches) and CHEST DISCOMFORT (chest tightness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 14-Feb-2021, the patient experienced DIZZINESS (dizziness three and a half hour after the shot). On an unknown date, the patient experienced HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches), CHEST DISCOMFORT (chest tightness), EAR PAIN (ear pain), FLUSHING (felt flush in their head) and PAIN IN EXTREMITY (arm soreness). The patient was treated with ALPRAZOLAM (XANAX) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches), CHEST DISCOMFORT (chest tightness), DIZZINESS (dizziness three and a half hour after the shot), EAR PAIN (ear pain), FLUSHING (felt flush in their head) and PAIN IN EXTREMITY (arm soreness) outcome was unknown.            Concomitant medications were not reported.    This case was linked to MOD-2021-074086 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Second dose information On 21-Apr-2021: Non-significant follow up appended.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Hypersensitivity, Pain in extremity
Clinical narrative: mild allergic reaction; fast heartbeat/rapid heart rate; can't breathe/ trouble breathing; chest tightness; ear pain; felt flush in their head; arm soreness; headaches; dizziness three and a half hour after the shot; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches) and CHEST DISCOMFORT (chest tightness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 14-Feb-2021, the patient experienced DIZZINESS (dizziness three and a half hour after the shot). On an unknown date, the patient experienced HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches), CHEST DISCOMFORT (chest tightness), EAR PAIN (ear pain), FLUSHING (felt flush in their head) and PAIN IN EXTREMITY (arm soreness). The patient was treated with ALPRAZOLAM (XANAX) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (mild allergic reaction), HEART RATE INCREASED (fast heartbeat/rapid heart rate), DYSPNOEA (can't breathe/ trouble breathing), HEADACHE (headaches), CHEST DISCOMFORT (chest tightness), DIZZINESS (dizziness three and a half hour after the shot), EAR PAIN (ear pain), FLUSHING (felt flush in their head) and PAIN IN EXTREMITY (arm soreness) outcome was unknown.            Concomitant medications were not reported.    This case was linked to MOD-2021-074086 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Second dose information On 21-Apr-2021: Non-significant follow up appended.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Erythema
Clinical narrative: Sore shoulder; Faint redness on arm; Weakness; Soreness of the stomach; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Soreness of the stomach) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Soreness of the stomach). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm) and ASTHENIA (Weakness) outcome was unknown and ABDOMINAL PAIN UPPER (Soreness of the stomach) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Migraine, Myalgia, Pyrexia
Clinical narrative: Diarrhea; Migraine headaches; Chills; Fever; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MIGRAINE (Migraine headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), MIGRAINE (Migraine headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches). At the time of the report, DIARRHOEA (Diarrhea), MIGRAINE (Migraine headaches), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow-up information received on 11-JUL-2021 contains no new information
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: pain is coming back again; became very severe; Shoulder pain; hip pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Shoulder pain), ARTHRALGIA (hip pain), PAIN (became very severe) and PAIN (pain is coming back again) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included Shingles (Received Flu shot and got shingles) in October 2020. Concomitant products included ALLOPURINOL, LISINOPRIL and FAMOTIDINE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced ARTHRALGIA (Shoulder pain) and ARTHRALGIA (hip pain). On 27-Jan-2021, the patient experienced PAIN (became very severe). On 09-Feb-2021, the patient experienced PAIN (pain is coming back again). The patient was treated with PREDNISONE for Polymyalgia, at an unspecified dose and frequency. On 27-Jan-2021, ARTHRALGIA (Shoulder pain) and ARTHRALGIA (hip pain) had resolved. At the time of the report, PAIN (became very severe) and PAIN (pain is coming back again) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: sore knee got worse; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore knee got worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (sore knee got worse). At the time of the report, ARTHRALGIA (sore knee got worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: fast heart beat; shortness of breath on and off; Difficulty breathing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not provided. Treatment information does not provided.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in August 2020. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued). At the time of the report, PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2121, Body temperature: 100 (High) 100 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. The patient had Covid in August, and she was experiencing every side effects except vomiting after receiving the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received included no new information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in August 2020. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued). At the time of the report, PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2121, Body temperature: 100 (High) 100 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. The patient had Covid in August, and she was experiencing every side effects except vomiting after receiving the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received included no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: more tired than after the first dose; sore arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (tired) and FATIGUE (more tired than after the first dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). In February 2021, the patient experienced FATIGUE (more tired than after the first dose). At the time of the report, PAIN IN EXTREMITY (sore arm), FATIGUE (tired) and FATIGUE (more tired than after the first dose) had resolved.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-033538, MOD-2021-033602, US-MODERNATX, INC.-MOD-2021-033538 (Linked Report). This case was linked to MOD-2021-033783.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up email added; Sender's Comments:  MOD-2021-033538:crosslink MOD-2021-033602:crosslink US-MODERNATX, INC.-MOD-2021-033538:crosslink
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Chills; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Extreme fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Extreme fatigue). At the time of the report, CHILLS (Chills) and FATIGUE (Extreme fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant product use was unknown by the reporter
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation, Faeces hard, Pain in extremity
Clinical narrative: Constipation; Hard stools; Right arm soreness; This spontaneous case was reported by a patient and describes the occurrence of CONSTIPATION (Constipation), FAECES HARD (Hard stools) and PAIN IN EXTREMITY (Right arm soreness) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CONSTIPATION (Constipation), FAECES HARD (Hard stools) and PAIN IN EXTREMITY (Right arm soreness). At the time of the report, CONSTIPATION (Constipation), FAECES HARD (Hard stools) and PAIN IN EXTREMITY (Right arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included stool softener.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Pain
Clinical narrative: nausea; severe pain; swollen gland; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PAIN (severe pain) and LYMPHADENOPATHY (swollen gland) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced NAUSEA (nausea), PAIN (severe pain) and LYMPHADENOPATHY (swollen gland). On 20-Feb-2021, NAUSEA (nausea) and PAIN (severe pain) had resolved. At the time of the report, LYMPHADENOPATHY (swollen gland) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD21-086694 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: contact info updated; Sender's Comments:  MOD21-086694:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Heat at site of injection; Itchiness at site of injection; Soreness at site of injection; Redness at site of injection; Raised area developed under site of injection; Raised rash 4 X 2 inches in diameter at site of injection; Soreness at site of injection; Redness at site of injection; Warm to touch at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to touch at site of injection), INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included OLMESARTAN, ALPRAZOLAM (XANAX), VITAMIN D3 and PANTOPRAZOLE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to touch at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection). On 01-Mar-2021, the patient experienced INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the second episode of INJECTION SITE PAIN (Soreness at site of injection), the second episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection). On 16-Feb-2021, INJECTION SITE WARMTH (Warm to touch at site of injection) had resolved. At the time of the report, INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the last episode of INJECTION SITE PAIN (Soreness at site of injection), the last episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included Benadryl.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth
Clinical narrative: Heat at site of injection; Itchiness at site of injection; Soreness at site of injection; Redness at site of injection; Raised area developed under site of injection; Raised rash 4 X 2 inches in diameter at site of injection; Soreness at site of injection; Redness at site of injection; Warm to touch at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to touch at site of injection), INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included OLMESARTAN, ALPRAZOLAM (XANAX), VITAMIN D3 and PANTOPRAZOLE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to touch at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection). On 01-Mar-2021, the patient experienced INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the second episode of INJECTION SITE PAIN (Soreness at site of injection), the second episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection). On 16-Feb-2021, INJECTION SITE WARMTH (Warm to touch at site of injection) had resolved. At the time of the report, INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the last episode of INJECTION SITE PAIN (Soreness at site of injection), the last episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included Benadryl.